Correlation between patient and clinician assessments of depression severity in the PREVENT study

Psychiatry Research

Volumn 177, Issue 1-2, 2010, Pages 177-183

  Dunlop, Boadie W ^a   Li, Thomas ^b   Kornstein, Susan G ^c   Friedman, Edward S ^d   Rothschild, Anthony J ^e   Pedersen, Ron ^b   Ninan, Philip ^b   Keller, Martin ^f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f BROWN UNIVERSITY   (United States)

Author keywords

Antidepressants; Clinical trials as a topic; Inventory of depressive symptoms; Major depressive disorder; Outcomes assessment; Psychiatric status rating scales; Ratings

Indexed keywords

FLUOXETINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MULTICENTER STUDY; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENT DISEASE; REMISSION; SECONDARY ANALYSIS;

ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952096376     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.02.008     Document Type: Article

References (29)

1. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Press, Washington, DC. 4th edn.
2. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
3. Bernstein I.H., Rush A.J., Suppes T., Trivedi M.H., Woo A., Kyutoku Y., Crismon M.L., Dennehy E., Carmody T.J. A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder. International Journal of Methods in Psychiatric Research 2009, 18:138-146.
4. Corruble E., Legrand J.M., Zvenigorowski H., Duret C., Guelfi J.D. Concordance between self-report and clinician's assessment of depression. Journal of Psychiatric Research 1999, 33:457-465.
5. Domken M., Scott J., Kelly P. What factors predict discrepancies between self and observer ratings of depression?. Journal of Affective Disorders 1994, 31:253-259.
6. Dorz S., Borgherini G., Conforti D., Scarso C., Magni G. Comparison of self-rated and clinician-rated measures of depressive symptoms: a naturalistic study. Psychology and Psychotherapy: Theory, Research and Practice 2004, 77:353-361.
7. Dunlop, B.W., Li, T., Kornstein, S.G., Friedman, E.S., Rothschild, A.J., Pedersen, R., Ninan, P.T., Keller, M., Trivedi, M.H., in press. Concordance between clinician and patient ratings as predictors of response, remission and recurrence in major depressive disorder. Journal of Psychiatric Research.
8. Faravelli C., Albanesi G., Poli E. Assessment of depression: a comparison of rating scales. Journal of Affective Disorders 1986, 11:245-253.
9. Greenberg R.P., Bornstein R.F., Greenberg M.D., Fisher S. A meta-analysis of antidepressant outcome under "blinder" conditions. Journal of Consulting and Clinical Psychology 1992, 60:664-669.
10. Guy W. Clinical Global Impressions. Publication ADM 76-338. ECDEU Assessment Manual for Psychopharmacology 1976, 217-222-217-222. US Department of Health, Education, and Welfare, Rockville, MD.
11. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-62.
12. Keller M., Trivedi M.H., Thase M.E., Shelton R.C., Kornstein S.G., Nemeroff C.B., Friedman E.S., Gelenberg A.J., Kocsis J.H., Dunner D.L., Hirschfeld R.M.A., Rothschild A.J., Ferguson J.M., Schatzberg A.F., Zajecka J.M., Pedersen R.D., Yan B., Ahmed S., Musgnung J., Ninan P.T. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the two-year and combined maintenance phases. Journal of Clinical Psychiatry 2007, 68:1246-1256.
13. Keller M.B., Trivedi M.H., Thase M.E., Shelton R.C., Kornstein S.G., Nemeroff C.B., Friedman E.S., Gelenberg A.J., Kocsis J.H., Dunner D.L., Dunlop B.W., Hirschfeld R.M., Rothschild A.J., Ferguson J.M., Schatzberg A.F., Zajecka J.M., Pedersen R., Yan B., Ahmed S., Schmidt M., Ninan P.T. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biological Psychiatry 2007, 62:1371-1379.
14. Lambert M.J., Hatch D.R., Kingston M.D., Edwards B.C. Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison. Journal of Consulting and Clinical Psychology 1986, 54:54-59.
15. Landin R., DeBrota D.J., DeVries T.A., Potter W.Z., Demitrack M.A. The impact of restrictive entry criterion during the placebo lead-in period. Biometrics 2000, 56:271-278.
16. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
17. Marton P., Kutcher S. The prevalence of cognitive distortion in depressed adolescents. Journal of Psychiatry and Neuroscience 1995, 20:33-38.
18. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
19. Mundt J.C., Katzelnick D.J., Kennedy S.H., Eisfeld B.S., Bouffard B.B., Greist J.H. Validation of an IVRS version of the MADRS. Journal of Psychiatric Research 2006, 40:243-246.
20. Nunnally J., Bernstein I.H. Psychometric Theory 1994, McGraw-Hill, New York. 3rd ed.
21. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 1996, 26:477-486.
22. Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., Markowitz J.C., Ninan P.T., Kornstein S., Manber R., Thase M.E., Kocsis J.H., Keller M.B. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 2003, 54:573-583.
23. Rush A.J., Trivedi M.H., Carmody T.J., Ibrahim H.M., Markowitz J.C., Keitner G.I., Kornstein S.G., Arnow B., Klein D.N., Manber R., Dunner D.L., Gelenberg A.J., Kocsis J.H., Nemeroff C.B., Fawcett J., Thase M.E., Russell J.M., Jody D.N., Borian F.E., Keller M.B. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology 2005, 30:405-416.
24. Rush A.J., Bernstein I.H., Trivedi M.H., Carmody T.J., Wisniewski S., Mundt J.C., Shores-Wilson K., Biggs M.M., Woo A., Nierenberg A.A., Fava M. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biological Psychiatry 2006, 59:493-501.
25. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackheim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR D report. American Journal of Psychiatry 2006, 163:1905-1917.
26. Senra C., Polaino A. Concordance between clinical and self-report depression scales during the acute phase and after treatment. Journal of Affective Disorders 1993, 27:13-19.
27. Thorndike R.L. Personnel Selection: Test and Measurement Techniques 1949, Wiley, New York.
28. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. American Journal of Psychiatry 2006, 163:28-40.
29. Wiberg M., Sundstrom A. A comparison of two approaches to correction of restriction of range in correlation analyses. Practical Assessment, Evaluation and Research 2009, 14(5):1-9.